Viewing StudyNCT01395056



Ignite Creation Date: 2024-05-05 @ 11:41 PM
Last Modification Date: 2024-10-26 @ 10:38 AM
Study NCT ID: NCT01395056
Status: COMPLETED
Last Update Posted: 2015-07-22
First Post: 2011-07-14

Brief Title: Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients
Sponsor:
Organization: Peking University Cancer Hospital Institute

Study Design

Study Type: OBSERVATIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: NONE_RETAINED
Bio Spec Description: about 4ml peripheral vein bloodparaffin section on metastatic tissue
Enrollment Count: 23
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Observational Models:
Name
Cohort
Time Perspective List:

Clinical Trial Statuses

Name
15059
Who Masked List: